Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 23, 2017

DrugPatentWatch Database Preview

Amantadine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for amantadine hydrochloride and what is the scope of amantadine hydrochloride patent protection?

Amantadine hydrochloride
is the generic ingredient in three branded drugs marketed by Solvay, Endo Pharms, Watson Labs Inc, Pharm Assoc, Teva Pharms, Cmp Pharma Inc, Bionpharma Inc, Mikart, Silarx, G And W Labs Inc, Actavis Elizabeth, Wockhardt, Newgen Pharms Llc, Hi Tech Pharma, Zydus Pharms Usa Inc, Watson Labs, Usl Pharma, Vintage, and Sandoz, and is included in twenty-four NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for amantadine hydrochloride. Thirty-seven suppliers are listed for this compound.

Summary for Generic Name: amantadine hydrochloride

Drug Master File Entries: see list7
Suppliers / Packagers: see list37
Bulk Api Vendors: see list89
Clinical Trials: see list1,020
Patent Applications: see list2,039
Therapeutic Class:Antivirals
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:amantadine hydrochloride at DailyMed

Pharmacology for Ingredient: amantadine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
amantadine hydrochloride
SYRUP;ORAL076352-001Sep 10, 2004DISCNNoNo► Subscribe► Subscribe
Watson Labs Inc
amantadine hydrochloride
CAPSULE;ORAL208107-001Dec 6, 2016ABRXNoNo► Subscribe► Subscribe
Watson Labs
amantadine hydrochloride
CAPSULE;ORAL071382-001Jan 21, 1987DISCNNoNo► Subscribe► Subscribe
amantadine hydrochloride
SYRUP;ORAL075060-001Dec 24, 1998AARXNoYes► Subscribe► Subscribe
Endo Pharms
amantadine hydrochloride
CAPSULE;ORAL016020-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Formulary management
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus